NCT03981809View on ClinicalTrials.gov

Screening Tool to Identify the Dominant Pain Mechanism in Cancer Survivors: PainsCan

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

June 13, 2019

Primary Completion Date

December 30, 2022

Study Completion Date

December 30, 2022

Conditions
Cancer SurvivorsCancer Pain
Interventions
DIAGNOSTIC_TEST

"Diagnostic test (PainsCan) for the identification of the dominant pain mechanisms in cancer survivers with persistent pain"

Easy-to-use screening tool to identify the dominant pain mechanism by using quick clinical tests and compare their accuracy and validity with complicated reference tests.

Trial Locations (1)

3000

University Hospital Leuven, Leuven

All Listed Sponsors
collaborator

Fund for Scientific Research, Flanders, Belgium

OTHER

lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT03981809 - Screening Tool to Identify the Dominant Pain Mechanism in Cancer Survivors: PainsCan | Biotech Hunter | Biotech Hunter